Immunosuppressant medications and mortality in inflammatory bowel disease

American Journal of Gastroenterology

Volumn 103, Issue 6, 2008, Pages 1428-1435

  Lewis, James D ^a,b   Gelfand, Joel M ^a   Troxel, Andrea B ^a   Forde, Kimberly A ^a   Newcomb, Craig ^a   Kim, Hopiy ^a   Margolis, David J ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 720 Blockley Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 44949242296     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01836.x     Document Type: Article

References (30)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004 126 : 1504 17.
2. Osterman MT. Risky business? Crohn's disease-related mortality. Inflamm Bowel Dis 2006 12 : 246 8.
3. Loftus EV Jr. Crohn's disease: Why the disparity in mortality? Gut 2006 55 : 447 9.
4. Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: Meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007 102 : 609 17.
5. Present DH, Meltzer SJ, Krumholz MP, et al. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med 1989 111 : 641 9.
6. Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005 54 : 1121 5.
7. Colombel JF, Loftus EV Jr., Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients. Gastroenterology 2004 126 : 19 31.
8. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006 4 : 621 30.
9. Gelfand J, Dattani H, Margolis D. The UK General Practice Research Database. In : Strom BL, ed. Pharmacoepidemiology. New York : John Wiley and Sons, 2005 : 337 46.
10. Lis Y, Mann RD. The VAMP research multi-purpose database in the U.K. J Clin Epidemiol 1995 48 : 431 43.
11. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998 45 : 419 25.
12. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991 302 : 766 8.
13. Jick H, Terris B, Derby L, et al. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992 1 : 347 9.
14. Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiology Drug Saf 2002 11 : 211 8.
15. Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: A population-based cohort study. Gastroenterology 2003 125 : 1583 90.
16. Aberra FN, Brensinger CM, Bilker WB, et al. Antibiotic use and the risk of flare of inflammatory bowel disease. Clin Gastroenterol Hepatol 2005 3 : 459 65.
17. Lewis JD, Aberra FN, Lichtenstein GR, et al. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 2004 126 : 665 73.
18. Lewis JD, Bilker WB, Brensinger C, et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001 121 : 1080 7.
19. Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005 129 : 819 26.
20. Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006 4 : 1483 90.
21. Lewis JD, Bilker WB, Weinstein RB, et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiology Drug Saf 2005 14 : 443 51.
22. Lewis JD, Brensinger C. Agreement between GPRD smoking data: A survey of general practitioners and a population-based survey. Pharmacoepidemiology Drug Saf 2004 13 : 437 41.
23. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 83.
24. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45 : 613 9.
25. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998 36 : 8 27.
26. Anonymous. Deaths: Age and sex. Health Stat Q 2006 29 : 50.
27. Armitage P, Berry G. Statistical methods in medical research. Oxford, UK : Blackwell Scientific Publications, 1987.
28. Wolters FL, Russel MG, Sijbrandij J, et al. for the European Collaborative Study Group on Inflammatory Bowel Disease. Crohn's disease: Increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 2006 55 : 510 8.
29. Jess T, Loftus EV Jr., Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: A long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006 55 : 1248 54.
30. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005 54 : 237 41.